Lundbeck to test antidepressant on Korean teenagers - Korea Biomedical Review

Korea Biomedical ReviewLundbeck to test antidepressant on Korean teenagersKorea Biomedical ReviewLundbeck Korea said it would conduct a phase-3 clinical trial on antidepressant Brintellix (ingredient: vortioxetine) for pediatric patients with a major depressive disorder in Korea. The Ministry of Food and Drug Safety recently approved the trial ...